Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification.

PeerJ · 2022 · PMC8855715 · PMID 35186504

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

One-way analysis of variance was used to compare different treatment groups, and p < 0.05 and p < 0.01 indicated significant and extremely significant differences, respectively.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.